Trine Alma Knudsen, MD, PhD student, Department of Haematology, Zealand University Hospital, Roskilde, Denmark, discusses the rationale of the DALIAH trial in patients with myeloproliferative neoplasms.
Trine Alma Knudsen, MD, PhD
Advertisement
Articles by Trine Alma Knudsen, MD, PhD
Advertisement
Latest Updated Articles
Dr. Knudsen Discusses the Rationale of the DALIAH Trial in MPNsPublished: July 10th 2018 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to Pelareorep Plus Bevacizumab/FOLFIRI in Second-Line KRAS-Mutant mCRC
2
On World Cancer Day, Northwell Highlights a Blueprint for Consistent, System-Wide Cancer Care
3
Acalabrutinib Delivers Strong Responses With Manageable Toxicities in Steroid-Refractory cGVHD
4
Enfortumab Vedotin Dose Reductions May Improve Tolerability Without Impeding OS in Advanced Urothelial Carcinoma
5